908 Devices Inc. (MASS)

NGM – Real vaqt narxi. Valyuta: USD

7.65

-0.28 (-3.53%)

Yopilishda: May 12, 2026, 4:00 PM EDT

Aksiya tahlili uchun eng kuchli vositalarga ega bo'ling

Finranks

Kompaniya

Biz haqimizda

Biz bilan bog'lanish

[email protected]

Bizni kuzating

Barcha huquqlar himoyalangan.

Foydalanish shartlari

9

908 Devices Inc. (MASS)

NGM – Real vaqt narxi. Valyuta: USD

7.65

-0.28 (-3.53%)

Yopilishda: May 12, 2026, 4:00 PM EDT

06.05.2026

908 Devices Inc. (MASS) Q1 2026 Earnings Call Transcript

06.05.2026

908 Devices Inc. (MASS) Reports Q1 Loss, Tops Revenue Estimates

908 Devices Inc. (MASS) came out with a quarterly loss of $0.15 per share in line with the Zacks Consensus Estimate. This compares to a loss of $0.22 per share a year ago.

06.05.2026

908 Devices Reports First Quarter 2026 Financial Results and Raises 2026 Revenue Outlook

BURLINGTON, Mass.--(BUSINESS WIRE)-- #ChemicalID--908 Devices Inc. (Nasdaq: MASS), a core small-cap growth company focused on purpose-built handheld chemical analysis tools for vital health, safety and defense tech applications, today reported financial results for the quarter ended March 31, 2026. “We delivered a strong start to 2026, achieving 14% revenue growth and meaningful margin expansion,” said Kevin J. Knopp, CEO and Co-founder. “We are also excited to announce the acquisition of NIRLAB AG, a strate.

06.05.2026

908 Devices Acquires NIRLAB AG, Expanding Its Narcotics Detection Portfolio

BURLINGTON, Mass.--(BUSINESS WIRE)-- #LawEnforcement--908 Devices Inc. (Nasdaq: MASS), a pioneer of purpose-built handheld devices for chemical analysis, announces that it has completed the acquisition of NIRLAB AG, a privately held company based in Lausanne, Switzerland. The company delivers AI-powered, cloud-connected near-infrared (NIR) spectroscopy to perform handheld chemical analysis of narcotics in seconds. This acquisition expands 908 Devices' analytical portfolio and strengthens its leadership in narcot.

21.04.2026

908 Devices Appoints Kola Otitoju as Chief Business & Strategy Officer and Announces an Inducement Grant Under Nasdaq Listing Rule 5635(c)(4)

BURLINGTON, Mass.--(BUSINESS WIRE)--908 Devices Inc. (Nasdaq: MASS), a pioneer of purpose-built handheld devices for chemical analysis, announces the appointment of Kola Otitoju as its Chief Business & Strategy Officer, a newly created executive position. Mr. Otitoju will oversee product and corporate strategy, business development, mergers and acquisitions, and partnership initiatives as 908 Devices expands its market presence across public health, safety, and defense-tech applications. Mr.

16.03.2026

908 Devices to Present at the Sidoti Small Cap Conference

BURLINGTON, Mass.--(BUSINESS WIRE)--908 Devices Inc. (Nasdaq: MASS), a core small-cap growth company focused on purpose-built handheld chemical analysis tools for vital health, safety and defense tech applications, announced that CEO and Co-founder Kevin J. Knopp and CFO Joe Griffith will virtually present and host investor meetings at the Sidoti Small Cap Conference on Wednesday, March 18, 2026. The Company presentation is scheduled to begin at 1:45 p.m. Eastern Time. A live audio webcast of t.

03.03.2026

908 Devices Inc. (MASS) Q4 2025 Earnings Call Transcript

Videolar

No Data

There is no data to display

Press-relizlar

06.05.2026

908 Devices Reports First Quarter 2026 Financial Results and Raises 2026 Revenue Outlook

BURLINGTON, Mass.--(BUSINESS WIRE)-- #ChemicalID--908 Devices Inc. (Nasdaq: MASS), a core small-cap growth company focused on purpose-built handheld chemical analysis tools for vital health, safety and defense tech applications, today reported financial results for the quarter ended March 31, 2026. “We delivered a strong start to 2026, achieving 14% revenue growth and meaningful margin expansion,” said Kevin J. Knopp, CEO and Co-founder. “We are also excited to announce the acquisition of NIRLAB AG, a strate.

06.05.2026

908 Devices Acquires NIRLAB AG, Expanding Its Narcotics Detection Portfolio

BURLINGTON, Mass.--(BUSINESS WIRE)-- #LawEnforcement--908 Devices Inc. (Nasdaq: MASS), a pioneer of purpose-built handheld devices for chemical analysis, announces that it has completed the acquisition of NIRLAB AG, a privately held company based in Lausanne, Switzerland. The company delivers AI-powered, cloud-connected near-infrared (NIR) spectroscopy to perform handheld chemical analysis of narcotics in seconds. This acquisition expands 908 Devices' analytical portfolio and strengthens its leadership in narcot.

21.04.2026

908 Devices Appoints Kola Otitoju as Chief Business & Strategy Officer and Announces an Inducement Grant Under Nasdaq Listing Rule 5635(c)(4)

BURLINGTON, Mass.--(BUSINESS WIRE)--908 Devices Inc. (Nasdaq: MASS), a pioneer of purpose-built handheld devices for chemical analysis, announces the appointment of Kola Otitoju as its Chief Business & Strategy Officer, a newly created executive position. Mr. Otitoju will oversee product and corporate strategy, business development, mergers and acquisitions, and partnership initiatives as 908 Devices expands its market presence across public health, safety, and defense-tech applications. Mr.

03.03.2026

908 Devices Reports Fourth Quarter and Full Year 2025 Financial Results and Provides 2026 Revenue Outlook

BURLINGTON, Mass.--(BUSINESS WIRE)--908 Devices Inc. (Nasdaq: MASS), a core small-cap growth company focused on purpose-built handheld chemical analysis tools for vital health, safety and defense tech applications, today reported financial results for the quarter and full year ended December 31, 2025. Q4 2025 and Full Year 2025 Financial Highlights Revenue of $17.4 million for the fourth quarter 2025, increasing 21% compared to the fourth quarter 2024 Revenue of $56.2 million for the full year.

Search stocks

908 Devices Inc. (MASS)

Aksiya tahlili uchun eng kuchli vositalarga ega bo'ling

Finranks

Kompaniya

Biz bilan bog'lanish

Bizni kuzating

908 Devices Inc. (MASS)

908 Devices Inc. (MASS) Q1 2026 Earnings Call Transcript

908 Devices Inc. (MASS) Reports Q1 Loss, Tops Revenue Estimates

908 Devices Reports First Quarter 2026 Financial Results and Raises 2026 Revenue Outlook

908 Devices Acquires NIRLAB AG, Expanding Its Narcotics Detection Portfolio

908 Devices Appoints Kola Otitoju as Chief Business & Strategy Officer and Announces an Inducement Grant Under Nasdaq Listing Rule 5635(c)(4)

908 Devices to Present at the Sidoti Small Cap Conference

908 Devices Inc. (MASS) Q4 2025 Earnings Call Transcript

Videolar

No Data

Press-relizlar

908 Devices Reports First Quarter 2026 Financial Results and Raises 2026 Revenue Outlook

908 Devices Acquires NIRLAB AG, Expanding Its Narcotics Detection Portfolio

908 Devices Appoints Kola Otitoju as Chief Business & Strategy Officer and Announces an Inducement Grant Under Nasdaq Listing Rule 5635(c)(4)

908 Devices Reports Fourth Quarter and Full Year 2025 Financial Results and Provides 2026 Revenue Outlook